You have 9 free searches left this month | for more free features.

Doxorubicin

Showing 1 - 25 of 2,767

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leiomyosarcoma Trial in Los Angeles (Lurbinectedin, Doxorubicin)

Recruiting
  • Leiomyosarcoma
  • Los Angeles, California
    Sarcoma Oncology Center
Oct 16, 2023

Advanced Soft-tissue Sarcoma Trial (LB-100 plus Doxorrubicin, Doxorubicin)

Not yet recruiting
  • Advanced Soft-tissue Sarcoma
  • LB-100 plus Doxorrubicin
  • Doxorubicin
  • (no location specified)
Apr 11, 2023

Cancer, Heart Failure, Arrhythmia Trial in Harbin (Control group:DH001 , Trial group: DH001 low-dose group, Trial group: DH001

Recruiting
  • Cancer
  • +4 more
  • Control group:DH001 placebo
  • +2 more
  • Harbin, Heilongjiang, China
    Harbin Institute of Hematology and Cancer
Oct 20, 2023

Cancer Trial (Empagliflozin 10 MG)

Not yet recruiting
  • Cancer
  • Empagliflozin 10 MG
  • (no location specified)
Oct 22, 2023

Hepatocellular Carcinoma, Liver Cancer Trial in Seoul (IDA-TACE, DOX-TACE)

Recruiting
  • Hepatocellular Carcinoma
  • Liver Cancer
  • IDA-TACE
  • DOX-TACE
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 27, 2023

Breast Cancer Stage 2 and 3 Trial (Fenofibrate, Placebo, Doxorubicin)

Not yet recruiting
  • Breast Cancer Stage 2 and 3
  • (no location specified)
Nov 24, 2023

Metastatic Leiomyosarcoma, Metastatic Sarcoma, Metastatic Soft Tissue Sarcoma Trial (Computed Tomography, Magnetic Resonance

Not yet recruiting
  • Metastatic Leiomyosarcoma
  • +5 more
  • Computed Tomography
  • +3 more
  • (no location specified)
Feb 2, 2023

Breast Cancer With Liposomal Doxorubicin Regimen

Recruiting
  • Breast Cancer
  • +4 more
  • Liposomal doxorubicin containing regimen
  • Hangzhou, Zhejiang, China
    Second Affiliate Hospital of Zhejiang University
Feb 7, 2023

Breast Cancer, Doxorubicin Induced Cardiotoxicity Trial in Damanhur (Placebo, Montelukast)

Recruiting
  • Breast Cancer
  • Doxorubicin Induced Cardiotoxicity
  • DamanhÅ«r, Elbehairah, Egypt
    Damanhour Oncology Center
Jul 16, 2023

Platinum-resistant Ovarian Cancer

Not yet recruiting
  • Ovarian Cancer
  • pegylated liposomal doxorubicin
  • (no location specified)
Aug 2, 2023

Solid Tumor, KRAS Mutation-Related Tumors Trial in Washington (NEROFE, Doxorubicin)

Recruiting
  • Solid Tumor
  • KRAS Mutation-Related Tumors
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Jan 23, 2023

Hodgkin Lymphoma Trial in Houston (Brentuximab vedotin, Doxorubicin Hydrochloride, Pembrolizumab)

Not yet recruiting
  • Hodgkin Lymphoma
  • Brentuximab vedotin
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 20, 2023

Large B-Cell Lymphoma Trial in Xi'an (Glofitamab, Polatuzumab vedotin, Rituximab)

Not yet recruiting
  • Large B-Cell Lymphoma
  • Xi'an, China
    First Affiliated Hospital of Medical College of Xi'an Jiaotong U
Sep 14, 2023

Metastatic Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma Trial in Hannover (Durvalumab and Tremelimumab,

Completed
  • Metastatic Adult Soft Tissue Sarcoma
  • Recurrent Adult Soft Tissue Sarcoma
  • Durvalumab and Tremelimumab
  • Doxorubicin
  • Hannover, Germany
    Medizinische Hochschule Hannover
Jan 18, 2023

Metastatic Soft Tissue Sarcoma, Advanced Soft Tissue Sarcoma Trial in Aurora (doxorubicin with AGEN1884 and AGEN2034)

Recruiting
  • Metastatic Soft Tissue Sarcoma
  • Advanced Soft Tissue Sarcoma
  • doxorubicin with AGEN1884 and AGEN2034
  • Aurora, Colorado
    University of Colorado Hospital
Jan 4, 2023

Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma

Active, not recruiting
  • Soft Tissue Sarcoma
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jan 25, 2023

Kaposi Sarcoma, HIV-1-infection Trial (Pegylated liposomal doxorubicin, Paclitaxel)

Not yet recruiting
  • Kaposi Sarcoma
  • HIV-1-infection
  • (no location specified)
Jan 20, 2023

Mitochondrial dysfUnction:Key Player in Doxorubicin-induced

Not yet recruiting
  • Doxorubicin Induced Cardiomyopathy
  • +3 more
  • 31-MRS at 7 Tesla (T)
  • Utrecht, Netherlands
  • +1 more
Feb 7, 2023

Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative Trial in Houston (Doxorubicin,

Recruiting
  • Metastatic Kidney Medullary Carcinoma
  • +4 more
  • Doxorubicin
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2023

High-Risk Localized Soft Tissue Sarcoma Trial in Shanghai (Pegylated Liposomal Doxorubicin, Doxorubicin, Anti-PD-1 mAb)

Recruiting
  • High-Risk Localized Soft Tissue Sarcoma
  • Pegylated Liposomal Doxorubicin
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 15, 2023

Ovarian Cancer Recurrent Trial in Beijing (IN10018, Placebo of IN10018, Pegylated Liposomal Doxorubicin)

Recruiting
  • Ovarian Cancer Recurrent
  • Beijing, China
    Cancer Hospital Chinese Academy of Medical Science and Peking Un
Aug 23, 2023

Breast Cancer Trial in Shanghai (Pegylated liposomal doxorubicin, Epirubicin, Cyclophosphamid)

Recruiting
  • Breast Cancer
  • Pegylated liposomal doxorubicin
  • +5 more
  • Shanghai, China
    Shanghai Pudong Hospital
Dec 11, 2022

Cutaneous Squamous Cell Carcinoma, Skin Cancers - Squamous Cell Carcinoma Trial in Pittsburgh (Microneedle Array Doxorubicin

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Skin Cancers - Squamous Cell Carcinoma
  • Microneedle Array Doxorubicin (MNA-D)
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Nov 28, 2022

Brain Tumor Trial in Washington (Exablate, Doxorubicin)

Recruiting
  • Brain Tumor
  • Exablate
  • Doxorubicin
  • Washington, District of Columbia
    Children's National Medical Center
Jan 4, 2023

Brain Tumor Trial in Toronto (Exablate, Doxorubicin)

Recruiting
  • Brain Tumor
  • Exablate
  • Doxorubicin
  • Toronto, Ontario, Canada
    Sunnybrook Research Institute
Jan 5, 2023